|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ITFG1-NETO2 (FusionGDB2 ID:40201) |
Fusion Gene Summary for ITFG1-NETO2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ITFG1-NETO2 | Fusion gene ID: 40201 | Hgene | Tgene | Gene symbol | ITFG1 | NETO2 | Gene ID | 81533 | 81831 |
Gene name | integrin alpha FG-GAP repeat containing 1 | neuropilin and tolloid like 2 | |
Synonyms | 2310047C21Rik|CDA08|LNKN-1|TIP | BTCL2|NEOT2 | |
Cytomap | 16q12.1 | 16q12.1 | |
Type of gene | protein-coding | protein-coding | |
Description | T-cell immunomodulatory proteinLINKINintegrin-alpha FG-GAP repeat-containing protein 1 | neuropilin and tolloid-like protein 2brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2neuropilin (NRP) and tolloid (TLL)-like 2 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q8TB96 | Q8NC67 | |
Ensembl transtripts involved in fusion gene | ENST00000568047, ENST00000320640, ENST00000544001, | ENST00000562435, ENST00000303155, | |
Fusion gene scores | * DoF score | 9 X 9 X 5=405 | 6 X 5 X 6=180 |
# samples | 9 | 8 | |
** MAII score | log2(9/405*10)=-2.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/180*10)=-1.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ITFG1 [Title/Abstract] AND NETO2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ITFG1(47409787)-NETO2(47117712), # samples:1 ITFG1(47409787)-NETO2(47120250), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ITFG1-NETO2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across ITFG1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across NETO2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-A2-A25D-01A | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - |
ChimerDB4 | BRCA | TCGA-A2-A25D-01A | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47120250 | - |
Top |
Fusion Gene ORF analysis for ITFG1-NETO2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000568047 | ENST00000562435 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - |
intron-3CDS | ENST00000568047 | ENST00000303155 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - |
In-frame | ENST00000320640 | ENST00000562435 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - |
In-frame | ENST00000320640 | ENST00000303155 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - |
Frame-shift | ENST00000544001 | ENST00000562435 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - |
Frame-shift | ENST00000544001 | ENST00000303155 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - |
intron-3CDS | ENST00000568047 | ENST00000562435 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47120250 | - |
intron-3CDS | ENST00000568047 | ENST00000303155 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47120250 | - |
Frame-shift | ENST00000320640 | ENST00000562435 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47120250 | - |
Frame-shift | ENST00000320640 | ENST00000303155 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47120250 | - |
Frame-shift | ENST00000544001 | ENST00000562435 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47120250 | - |
Frame-shift | ENST00000544001 | ENST00000303155 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47120250 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000320640 | ITFG1 | chr16 | 47409787 | - | ENST00000562435 | NETO2 | chr16 | 47117712 | - | 7048 | 949 | 229 | 1053 | 274 |
ENST00000320640 | ITFG1 | chr16 | 47409787 | - | ENST00000303155 | NETO2 | chr16 | 47117712 | - | 3117 | 949 | 229 | 1053 | 274 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000320640 | ENST00000562435 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - | 0.00031886 | 0.9996811 |
ENST00000320640 | ENST00000303155 | ITFG1 | chr16 | 47409787 | - | NETO2 | chr16 | 47117712 | - | 0.000325516 | 0.99967444 |
Top |
Fusion Genomic Features for ITFG1-NETO2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ITFG1-NETO2 |
Go to FGviewer for the breakpoints of chr16:47409787-chr16:47117712 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ITFG1 | NETO2 |
FUNCTION: Modulator of T-cell function. Has a protective effect in graft versus host disease model (By similarity). {ECO:0000250}. | FUNCTION: Accessory subunit of neuronal kainate-sensitive glutamate receptors, GRIK2 and GRIK3. Increases kainate-receptor channel activity, slowing the decay kinetics of the receptors, without affecting their expression at the cell surface, and increasing the open probability of the receptor channels. Modulates the agonist sensitivity of kainate receptors. Slows the decay of kainate receptor-mediated excitatory postsynaptic currents (EPSCs), thus directly influencing synaptic transmission (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | NETO2 | chr16:47409787 | chr16:47117712 | ENST00000562435 | 7 | 9 | 369_525 | 332.3333333333333 | 526.0 | Topological domain | Cytoplasmic | |
Tgene | NETO2 | chr16:47409787 | chr16:47117712 | ENST00000562435 | 7 | 9 | 348_368 | 332.3333333333333 | 526.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ITFG1 | chr16:47409787 | chr16:47117712 | ENST00000320640 | - | 7 | 18 | 258_293 | 240.0 | 613.0 | Repeat | Note=FG-GAP%3B atypical |
Hgene | ITFG1 | chr16:47409787 | chr16:47117712 | ENST00000320640 | - | 7 | 18 | 567_587 | 240.0 | 613.0 | Transmembrane | Helical |
Tgene | NETO2 | chr16:47409787 | chr16:47117712 | ENST00000562435 | 7 | 9 | 177_292 | 332.3333333333333 | 526.0 | Domain | CUB 2 | |
Tgene | NETO2 | chr16:47409787 | chr16:47117712 | ENST00000562435 | 7 | 9 | 296_332 | 332.3333333333333 | 526.0 | Domain | LDL-receptor class A | |
Tgene | NETO2 | chr16:47409787 | chr16:47117712 | ENST00000562435 | 7 | 9 | 45_159 | 332.3333333333333 | 526.0 | Domain | CUB 1 | |
Tgene | NETO2 | chr16:47409787 | chr16:47117712 | ENST00000562435 | 7 | 9 | 23_347 | 332.3333333333333 | 526.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for ITFG1-NETO2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000320640_ENST00000562435_TCGA-A2-A25D-01A_ITFG1_chr16_47409787_-_NETO2_chr16_47117712_length(transcript)=7048nt_BP=949nt ACTGTCGGGAGGCGCGCCTGCCGGAAGTGAGCGTGAGGGCGGCTTTCACCCTAGCTCCACTGCTTTTTTAGCGTCGGAAGGGCAGCCCTA GTGGGAGAGAGAAAAAGGAGCCGGCAGCGGCTCTTACGCGTCCCGGGGCTGCGCGCCACTCTCTCGGCCGGTAACGCGGTGCTTTGCGGC TGTCGTCAAGCGCGGCGTTGGGCCGGCGGGCGGGGGCTGAGGGGCTGCCATGGCGGCGGCGGGCCGGCTCCCGAGCTCCTGGGCCCTCTT CTCGCCGCTCCTCGCAGGGCTTGCACTACTGGGAGTCGGGCCGGTCCCAGCGCGGGCGCTGCACAACGTCACGGCCGAGCTCTTTGGGGC CGAGGCCTGGGGCACCCTTGCGGCTTTCGGGGACCTCAACTCCGACAAGCAGACGGATCTCTTCGTGCTGCGGGAAAGAAATGACTTAAT CGTCTTTTTGGCAGACCAGAATGCACCCTATTTTAAACCCAAAGTAAAGGTATCTTTCAAGAATCACAGTGCATTGATAACAAGTGTAGT CCCTGGGGATTATGATGGAGATTCTCAAATGGATGTCCTTCTGACATATCTTCCCAAAAATTATGCCAAGAGTGAATTAGGAGCTGTTAT CTTCTGGGGACAAAATCAAACATTAGATCCTAACAATATGACCATACTCAATAGGACTTTTCAAGATGAGCCACTAATTATGGATTTCAA TGGTGATCTAATTCCTGATATTTTTGGTATCACAAATGAATCCAACCAGCCACAGATACTATTAGGAGGGAATTTATCATGGCATCCAGC ATTGACCACTACAAGTAAAATGCGAATTCCACATTCTCATGCATTTATTGATCTGACTGAAGATTTTACAGCAGATTTATTCCTGACGAC ATTGAATGCCACCACTAGTACCTTCCAGTTTGAAATATGGGAAAATTTGAAAAGAAAAAAGCAGGAGTATTTGAACAAATCACTAAGACT CATGGAACAATTATTGGCATTACTTCAGGGATTGTCTTGGTCCTTCTCATTATTTCTATTTTAGTACAAGTGAAACAGCCTCGAAAAAAG GTCATGGCTTGCAAAACCGCTTTTAATAAAACCGGGTTCCAAGAAGTGTTTGATCCTCCTCATTATGAACTGTTTTCACTAAGGGACAAA GAGATTTCTGCAGACCTGGCAGACTTGTCGGAAGAATTGGACAACTACCAGAAGATGCGGCGCTCCTCCACCGCCTCCCGCTGCATCCAC GACCACCACTGTGGGTCGCAGGCCTCCAGCGTCAAACAAAGCAGGACCAACCTCAGTTCCATGGAACTTCCTTTCCGAAATGACTTTGCA CAACCACAGCCAATGAAAACATTTAATAGCACCTTCAAGAAAAGTAGTTACACTTTCAAACAGGGACATGAGTGCCCTGAGCAGGCCCTG GAAGACCGAGTAATGGAGGAGATTCCCTGTGAAATTTATGTCAGGGGGCGAGAAGATTCTGCACAAGCATCCATATCCATTGACTTCTAA TCTTCTGCTAATGGTGATGTGAATTCTTAGGGTGTGTACGTACGCAGCCTCCAGGGCACCATACTGTTTCCAGCAGCCAACCCTTTTCTC CCATCACAACTACGAAGACCTTGATTTACCGTTAACCTATTGTATGGTGATGTTTTTATTCTCTCAGGCAGTCTATATATGTTAAACCAA TCAAGGAACTTACTCTATTCAGTGGAAACAATAATCATCTCTATTGCTTGGTGTCATTTATAGGAAGCACTGCCAGTTAAAGAGCATTAG AAGAGGTGGTTGGATGGAGCCAGGCTCAGGCTGCCTCTTCGTTTTAGCAACAAGAAGACTGCTCTTGACTGATAACAGCTCTGTCAATAT TTTGATGCCACAATAAACTTGATTTTTCTTTACATTCCTTTTATTTTTCCTTTCTCTAAATTTAATTTGTTTTATAAGCCTATCGTTTTA CCATTTCATTTTCTTACATAAGTACAAGTGGTTAATGTACCACATACTTCAGTATAGGCATTTGTTCTTGAGTGTGTCAAAATACAGCTA GTTACTGTGCCAATTAAGACCCAGTTGTATTTCACCCATCTGTTTCTTCTTGGCTAATCTCTGTACTTCTGCCTTTTAATTACTGGGCCC TTATTCCTTATTTTCTGTGAGAAATAATAGATGATATGATTTATTACCTTTCAATTATATTTTTCTCAGTTATACTAGAAAATTTCATAA TCCTGGGATATATGTACCATTGTCAGCTATGACTAAAAATTTGAAAAAGATAAAAATTTCTAGCAAGCCTTTGAAGTTTACCAAGTATAG TCACATTCAGTGACAGCCCATTCATTCCAGTAAAGAATCATTTCATTCACTTTGGGAGAGGCCTATAATTACATTTATTTGCAATGTTTC TCTTCGCTAGATTGTTACATAGCTCCCATTCTGTTGGTTTTGCTTACAGCATATGGTAACCAAGGTTAGATGCCAGTTAAAATTCCTTAG AAATTGGATGAGCCTTGAGATTGCTTCTTAACTGGGACATGACATTTTTCTAGCTCTTATCAAGAATAACAACTTCCACTTTTTTTTAAA CTGCACTTTTGACTTTTTTTATGGTATAAAAACAATAATTTATAAACATAAAAGCTCATTGTGTTTTTTAGACTTTTGATATTATTTGAT ACTGTACAAACTTTATTAAATCAAGATGAAAGACCTACAGGACAGATTCCTTTCAGTGTTCACATCAGTGGCTTTGTATGCAAATATGCT GTGTTGGACCTGGACGCTATAACTTATTGTAAAGACCTTGGAAATGTGGACATAAGCTCTTTCTTTCCTTTTGTTACTGTATTTAGTTTG TGATAAATTTTTCACTGTGTGATATTTATGCTCTAAATCACTACACAAATCCCATATTAAAATATACATTGTACCTGACCCTTTAATCAT GTTATTTATGCCACCAAGGTTGTGGATCTTAAGGTATGTATGGAAAGGAACTCATTTATCAAATTGTAAGTAATACAGACATGCCATTTA AAAGAGGTAAATTCTTGTTTTCTATATTTTGTTAGTAAATTCTCAATGAAATAAGTTGAAGTTTCACTGGATTTCATTAACTTTTAAATA TTACATATATGTGTTTTCTCAGATTAGTGAAAATTGTGACCTTAAATTTAATACACATATACTGCCTCAGAGTGCTTTCTTGTATCAAAA TTTTTGTTTTTTAAAAAAGTAGATAATATTTAGGAGACAGAAAAACCTATACATAATGTATTCATGATTTAAATTTTTTTAAGTCAGCCT AGTTTCTTGTTTTAAAAATATAACGTGGAAACATGAAAAGACTTGATGCATATAATATTCAATGAACTAATACCAGAGACAGCTAAGTTT TTTCAGTAGTTATGCTGAATAAGCATTTTAGTAGGTAACTTACACCAGCTAACATTTGAACAGCATAATAAATACTTAATATAACAACAA CTATGATCTTATGATGATAAAAGGGAAGTTAGCATATTTTCTATGTAAAATTATTCATTTTTTAAAATAGCTGTTAAACCTATATTTAAT CTTTAGATTATAATAGCAAATAATACAGTATGCTAAACTATAGTCACTTGTAACTACATTTTTGTTTTTGAAATTTGATTTCTATTTATA AGGTCTTGAAGAGGCCTACAAAATACAGAGCCTTTAAAGAAGACATAACAGTAAAATAGAAGTACACAGTTTTATACGAGTCAATGTAGC AAGTAACATTTAGACAGTAAGTTTGGTTCTGAATTTTCTGGCTGCTAAAACACTTTTTGCTTTTCACAGTAAAAAAACTTATGTGCAGAG GCTAATTTCCTCTTGAACTACAGCATGAGGGTCTGTATATAGGAACATTTCTTCAGAATGTAAAAAAGATGCAAAATGGAGACAGAGGTT ATAATGGTGCTTCTTAACCCAGTGAAGGCACAACTTAATGTCGTCTAGGAACATTGGTTTAGGGTCAGTCTGTATTTTCAGGGATAGAAC TAAAGAACCAGATGATCAATAGCTAAGCCAGCCTTAGCCTGTCACATGTTATACACCTTCATTGAATCATAGATGGGCATTAGATCTCAT TTATTTATTAAACTTCTCTATGCTTTTGGAAGAGGTAAGAATGGAACTAATAAATCTTAGGCATTATTGCCAGAATAATGCTAATTGCTG TATATACAGCCTTTAATCTTTGAGATCAGTGAGAAAACTTTATAAATTGCTTACTAAAATGAAAGCCATAAAATTTAATAACAGAAGACA TGAAATTTAGCAATCTTGTGGAATTCATTACACAGTATTAACTGTCACGCAGGGTACCCCACACAGTGTCCCAGTGTTGAACACAAAATG CAAATCTGGAAGGGATAAATATCTTCAATTCAGAAACAGCATTAAGTATACCTGTATAATACTGTCACCATTATCTTCCATCTGCAATTC ACCGCATCATCCCCCAAATGCCCACAGATCTATTGCAGGAAACCTACTAATCCCAACATCTAAAGCATGTAGGAATAAGATGTGATATTC CTTTTGTGTGTGGGGAGAGTGTCAATCTAAACGTTTAACAAAAGGCAAAGAATGTTCACATTTCACATCACAAAAGAGATTTCAAAGACT CCTTTAACCCGACAGCGCTTATGTCAGTGTCTTTGTCATGTTTCATAGAATTGTTAGACTTTAAAAGAACCTCCTGAAAGTCTGCCTCTG AACATTTGTATGGTTCTGCCAATGTCTGATGAGAAGAATGCTTCCCTGTTTGAGGAGTGTGTTCACTGATGAGAGGGGACGGGAGAAGCC TGGTTGTGATTTCAGGAATAATTCTCAAAGGAGATTATACTCTTATTGCAAAATGGGGTCTGCTATATATTGTTCATGTCACTTTATTGC AAGTGACATGAATTATATGACATTAAAAATAATATGCCTTGAATCACACTGATTAGACCCAGAAGGATCATTGAGTTTTTGGTGGTTTTA AAGATCCAAGAAAGACCTATCTAGCCCAAGTGTATGAATGAGAAGACTGAAGCCCACAGAAGTGAACTCAGCACCAGTGTCTCAAGAACC CCAGTACTCTGGTTTTTTTCTTTTTTGAGACGGAGTCTCGCTCTGTCGCCCAGGCTGGAGTGCAGTGGCGCGATCTCGGCTCACTGCAAG CTCCGCCTCCCGGGTTCACGCTATTCTCCTGCCTCAGTCTCCCAAGTAGCTGGGACTACAGGCGCCCGACACCATGCCCGGCTAATTTCT TGTATTTTTAGTAGAGACGGGGTTTCACCGTGTTAGCCAGGATAGTCTCAATCTCCTGACCTCGTGATCCACCCGCCTCGGCCTCCCAAA GTGCTGGGATTACAGGCGTGAGCCACCGCGCCTGGCCTTCTGTTTTTGTTTTTCTGTTTTTTTGTTTTTTGAGACAGAGTCTCGCTCTGT CACCCAGGCTAGAGTGCAGTGGCGTGATCTCGGCTCACTGCAAGCTCCGCCTCCCGGGTTCATGCCATTCTCCTGTCTCAGCCTCTCGAG TAGCTGGGACTACAGGCGCCCGCCACCATGCCCGGCTAATTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTAGCCAGGATGGT CTCGATCTCCTGACCTCGTGATCCGCCCGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGAGTGAGCCAAGGCGCCCAGCCCAGCTGTAC GTTTTAAAAGTCAAGCACTTCTGTTTAGCAGCCCATGTAAGCTTGTCAATCATTCTGAATTGAAATGTAATTTATTCTGTAATTTCTTCA ATGCATTATATTTCCCCTTTTCTTTAAATGTATGTAACATTGTGTTCTACAGTTTTGCTGCCATGATTCCTTGGCACCGTGAATTCTTAC TAAGCAATGTTTGTTAACAGTATACAGGCTCGATACTAGGCAGGAAGAGCTCCTGTGTTCTTGCTTTTTTGATCTTTTTTAAATCTAAAG GAGACGTGTATTCTAGAAATTAAATATTTGTGTGCCATATCTCTTGAGTTTTGGAGAATGATTGGAGTTTGAGTTACTGTAAATAACAAG ATTATCTTGGATATTTTAGTTTTCTGCAAAATCACTTATGTTTTATATACCTCTGCTAATAATTCAAAACTCTGAATTTGCTTTACTTTA ACTTTTTAAAAATGTATTTTTGCAATTGGTTTAATGACTACCAAAGCCTAAAAAGCTAATGACTAGGGTGCATGTTTAGTATGCACTGTC TAGTGTAAGCTTTTTAAAAGCAGTAGATTTTTATTAGAGATGAACTTCCAGGCCATATGAGAATATGCTTAATCCTAGATTTGGCATTTT ATAGAAAAGAATTTTGACTCTTGAACTAGAATTAAAAACTTGTTCTGATTTCCTTGCTTGCCTCAATTTCTAAAGTCTAGAAGTGGCAAA TAATTTAGATCACTTATACCAACAGAATCTGTATTTCCTTCCGGGGCAAAGTTGGCATTTCCTATCCACTAGCTTCCAAAATACAATAAT CCTAGTTATGATAAGGGCAACTTTATTTTATTACACTTAGAACCATTTTATGTTTTCAAATTCATTAATCTTCAAGTGAAGATGAACTAA AGAAAAAAATGCGTTTTGTCCCAGGTTGCCTGCAGGTTGCAGTCTGCTGCATCCGGTCACTGAAGAGGCAGTGAGGACTGTCACAGAGTG GGCTGGAGAGCCAAGCTGTTCTTTCGGGGTGCACAGTGCACCAGCCATAACACAGCTTAGAAACATGGATGAGTATACCTCAAGACAGGT GAACACGGAGTGGGGAGCAAAAGAAGGCAGAAACTCCTCTGAGTTTCACAAGCATCAGGCACAGATCAGGGCACAGAGGAAGAAGAAAGA AGGTTTACCACTGGTCTGTCTCTGTAAATTGTTACAGAGCAATTTTACTTTGTGTTATTTAGGATCAAGAAACAAGTGTTATTTAAAAGT >In-frame_ENST00000320640_ENST00000562435_TCGA-A2-A25D-01A_ITFG1_chr16_47409787_-_NETO2_chr16_47117712_length(amino acids)=274AA_start in transcript=229_stop in transcript=1053 MAAAGRLPSSWALFSPLLAGLALLGVGPVPARALHNVTAELFGAEAWGTLAAFGDLNSDKQTDLFVLRERNDLIVFLADQNAPYFKPKVK VSFKNHSALITSVVPGDYDGDSQMDVLLTYLPKNYAKSELGAVIFWGQNQTLDPNNMTILNRTFQDEPLIMDFNGDLIPDIFGITNESNQ PQILLGGNLSWHPALTTTSKMRIPHSHAFIDLTEDFTADLFLTTLNATTSTFQFEIWENLKRKKQEYLNKSLRLMEQLLALLQGLSWSFS -------------------------------------------------------------- >In-frame_ENST00000320640_ENST00000303155_TCGA-A2-A25D-01A_ITFG1_chr16_47409787_-_NETO2_chr16_47117712_length(transcript)=3117nt_BP=949nt ACTGTCGGGAGGCGCGCCTGCCGGAAGTGAGCGTGAGGGCGGCTTTCACCCTAGCTCCACTGCTTTTTTAGCGTCGGAAGGGCAGCCCTA GTGGGAGAGAGAAAAAGGAGCCGGCAGCGGCTCTTACGCGTCCCGGGGCTGCGCGCCACTCTCTCGGCCGGTAACGCGGTGCTTTGCGGC TGTCGTCAAGCGCGGCGTTGGGCCGGCGGGCGGGGGCTGAGGGGCTGCCATGGCGGCGGCGGGCCGGCTCCCGAGCTCCTGGGCCCTCTT CTCGCCGCTCCTCGCAGGGCTTGCACTACTGGGAGTCGGGCCGGTCCCAGCGCGGGCGCTGCACAACGTCACGGCCGAGCTCTTTGGGGC CGAGGCCTGGGGCACCCTTGCGGCTTTCGGGGACCTCAACTCCGACAAGCAGACGGATCTCTTCGTGCTGCGGGAAAGAAATGACTTAAT CGTCTTTTTGGCAGACCAGAATGCACCCTATTTTAAACCCAAAGTAAAGGTATCTTTCAAGAATCACAGTGCATTGATAACAAGTGTAGT CCCTGGGGATTATGATGGAGATTCTCAAATGGATGTCCTTCTGACATATCTTCCCAAAAATTATGCCAAGAGTGAATTAGGAGCTGTTAT CTTCTGGGGACAAAATCAAACATTAGATCCTAACAATATGACCATACTCAATAGGACTTTTCAAGATGAGCCACTAATTATGGATTTCAA TGGTGATCTAATTCCTGATATTTTTGGTATCACAAATGAATCCAACCAGCCACAGATACTATTAGGAGGGAATTTATCATGGCATCCAGC ATTGACCACTACAAGTAAAATGCGAATTCCACATTCTCATGCATTTATTGATCTGACTGAAGATTTTACAGCAGATTTATTCCTGACGAC ATTGAATGCCACCACTAGTACCTTCCAGTTTGAAATATGGGAAAATTTGAAAAGAAAAAAGCAGGAGTATTTGAACAAATCACTAAGACT CATGGAACAATTATTGGCATTACTTCAGGGATTGTCTTGGTCCTTCTCATTATTTCTATTTTAGTACAAGTGAAACAGCCTCGAAAAAAG GTCATGGCTTGCAAAACCGCTTTTAATAAAACCGGGTTCCAAGAAGTGTTTGATCCTCCTCATTATGAACTGTTTTCACTAAGGGACAAA GAGATTTCTGCAGACCTGGCAGACTTGTCGGAAGAATTGGACAACTACCAGAAGATGCGGCGCTCCTCCACCGCCTCCCGCTGCATCCAC GACCACCACTGTGGGTCGCAGGCCTCCAGCGTCAAACAAAGCAGGACCAACCTCAGTTCCATGGAACTTCCTTTCCGAAATGACTTTGCA CAACCACAGCCAATGAAAACATTTAATAGCACCTTCAAGAAAAGTAGTTACACTTTCAAACAGGGACATGAGTGCCCTGAGCAGGCCCTG GAAGACCGAGTAATGGAGGAGATTCCCTGTGAAATTTATGTCAGGGGGCGAGAAGATTCTGCACAAGCATCCATATCCATTGACTTCTAA TCTTCTGCTAATGGTGATGTGAATTCTTAGGGTGTGTACGTACGCAGCCTCCAGGGCACCATACTGTTTCCAGCAGCCAACCCTTTTCTC CCATCACAACTACGAAGACCTTGATTTACCGTTAACCTATTGTATGGTGATGTTTTTATTCTCTCAGGCAGTCTATATATGTTAAACCAA TCAAGGAACTTACTCTATTCAGTGGAAACAATAATCATCTCTATTGCTTGGTGTCATTTATAGGAAGCACTGCCAGTTAAAGAGCATTAG AAGAGGTGGTTGGATGGAGCCAGGCTCAGGCTGCCTCTTCGTTTTAGCAACAAGAAGACTGCTCTTGACTGATAACAGCTCTGTCAATAT TTTGATGCCACAATAAACTTGATTTTTCTTTACATTCCTTTTATTTTTCCTTTCTCTAAATTTAATTTGTTTTATAAGCCTATCGTTTTA CCATTTCATTTTCTTACATAAGTACAAGTGGTTAATGTACCACATACTTCAGTATAGGCATTTGTTCTTGAGTGTGTCAAAATACAGCTA GTTACTGTGCCAATTAAGACCCAGTTGTATTTCACCCATCTGTTTCTTCTTGGCTAATCTCTGTACTTCTGCCTTTTAATTACTGGGCCC TTATTCCTTATTTTCTGTGAGAAATAATAGATGATATGATTTATTACCTTTCAATTATATTTTTCTCAGTTATACTAGAAAATTTCATAA TCCTGGGATATATGTACCATTGTCAGCTATGACTAAAAATTTGAAAAAGATAAAAATTTCTAGCAAGCCTTTGAAGTTTACCAAGTATAG TCACATTCAGTGACAGCCCATTCATTCCAGTAAAGAATCATTTCATTCACTTTGGGAGAGGCCTATAATTACATTTATTTGCAATGTTTC TCTTCGCTAGATTGTTACATAGCTCCCATTCTGTTGGTTTTGCTTACAGCATATGGTAACCAAGGTTAGATGCCAGTTAAAATTCCTTAG AAATTGGATGAGCCTTGAGATTGCTTCTTAACTGGGACATGACATTTTTCTAGCTCTTATCAAGAATAACAACTTCCACTTTTTTTTAAA CTGCACTTTTGACTTTTTTTATGGTATAAAAACAATAATTTATAAACATAAAAGCTCATTGTGTTTTTTAGACTTTTGATATTATTTGAT ACTGTACAAACTTTATTAAATCAAGATGAAAGACCTACAGGACAGATTCCTTTCAGTGTTCACATCAGTGGCTTTGTATGCAAATATGCT GTGTTGGACCTGGACGCTATAACTTATTGTAAAGACCTTGGAAATGTGGACATAAGCTCTTTCTTTCCTTTTGTTACTGTATTTAGTTTG TGATAAATTTTTCACTGTGTGATATTTATGCTCTAAATCACTACACAAATCCCATATTAAAATATACATTGTACCTGACCCTTTAATCAT GTTATTTATGCCACCAAGGTTGTGGATCTTAAGGTATGTATGGAAAGGAACTCATTTATCAAATTGTAAGTAATACAGACATGCCATTTA >In-frame_ENST00000320640_ENST00000303155_TCGA-A2-A25D-01A_ITFG1_chr16_47409787_-_NETO2_chr16_47117712_length(amino acids)=274AA_start in transcript=229_stop in transcript=1053 MAAAGRLPSSWALFSPLLAGLALLGVGPVPARALHNVTAELFGAEAWGTLAAFGDLNSDKQTDLFVLRERNDLIVFLADQNAPYFKPKVK VSFKNHSALITSVVPGDYDGDSQMDVLLTYLPKNYAKSELGAVIFWGQNQTLDPNNMTILNRTFQDEPLIMDFNGDLIPDIFGITNESNQ PQILLGGNLSWHPALTTTSKMRIPHSHAFIDLTEDFTADLFLTTLNATTSTFQFEIWENLKRKKQEYLNKSLRLMEQLLALLQGLSWSFS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ITFG1-NETO2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ITFG1-NETO2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ITFG1-NETO2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | NETO2 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Tgene | NETO2 | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
Tgene | NETO2 | C0220636 | Malignant neoplasm of salivary gland | 1 | CTD_human |